Last 12 months
Inside the activity.
0 purchase rows · 106 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 10 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 16 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2017 Filed May 15, 2017 09:09 UTC |
KIRK RANDAL JDirector · 10% owner
|
Exercise / conversionCommon Stock | 10,000 | $10.37 | $103,700.00 |
DisclosureSEC source: 0001140361-17-020229 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,562,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 9, 2017 22:00 UTC |
MATSUI CONNIEDirector
|
Exercise / conversionOptions to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $10.37 | $0.00 |
DisclosureSEC source: 0001179110-17-006946 · edgar.xml · derivative · entry 2 MATSUI CONNIE · CIK 0001236537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became fully vested and exercisable on the date immediately preceding the date of the annual stockholders' meeting following the date of grant. Read SEC document |
| May 08, 2017 Filed May 9, 2017 22:00 UTC |
MATSUI CONNIEDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.37 | $103,700.00 |
DisclosureSEC source: 0001179110-17-006946 · edgar.xml · nonDerivative · entry 1 MATSUI CONNIE · CIK 0001236537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:58 UTC |
MATSUI CONNIEDirector
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006701 · edgar.xml · nonDerivative · entry 1 MATSUI CONNIE · CIK 0001236537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,388 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:59 UTC |
Posard Matthew L.Director
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006704 · edgar.xml · nonDerivative · entry 1 Posard Matthew L. · CIK 0001543792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,388 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:56 UTC |
Kelley Kenneth JDirector
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006699 · edgar.xml · nonDerivative · entry 1 Kelley Kenneth J · CIK 0001291219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,388 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:55 UTC |
Henderson Jeffrey WilliamDirector
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006695 · edgar.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,742 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:53 UTC |
Daly James MDirector
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006690 · edgar.xml · nonDerivative · entry 1 Daly James M · CIK 0001560782 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,337 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 5, 2017 20:52 UTC |
BIZZARI JEAN-PIERREDirector
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006686 · edgar.xml · nonDerivative · entry 1 BIZZARI JEAN-PIERRE · CIK 0001630914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,949 F1 · shares: Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 and (ii) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 04, 2017 Filed May 8, 2017 16:01 UTC |
KIRK RANDAL JDirector · 10% owner
|
GrantCommon Stock | 14,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018828 · doc1.xml · nonDerivative · entry 1 KIRK RANDAL J · CIK 0001091823 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,552,388 F1 · shares: Represents annual restricted stock grant as compensation for services pursuant to the Halozyme Therapeutics, Inc. 2011 Stock Plan. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the issuer's next Annual Meeting. Read SEC document |
| April 13, 2017 Filed Apr 14, 2017 18:03 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-005998 · edgar.xml · derivative · entry 3 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the Issuer. F2 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the Issuer. Read SEC document |
| April 13, 2017 Filed Apr 14, 2017 18:03 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Tax withholdingCommon Stock | 2,583 | $12.81 | $33,088.23 |
DisclosureSEC source: 0001179110-17-005998 · edgar.xml · nonDerivative · entry 2 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,799 F1 · shares: The reported disposition of 2,583 shares represents the shares that were withheld by the Issuer as payment for minimum statutory tax withholding requirements. Read SEC document |
| April 13, 2017 Filed Apr 14, 2017 18:03 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Exercise / conversionCommon Stock | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-005998 · edgar.xml · nonDerivative · entry 1 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:06 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
GrantRestricted Stock Units · Derivative | 45,568 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003120 · edgar.xml · derivative · entry 2 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,568 Underlying: Common Stock · 45,568 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date then one-fourth on each anniversary date thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:06 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
GrantOption to Purchase Common Stock · Derivative | 72,925 | $0.00 Strike: $12.07 | $0.00 |
DisclosureSEC source: 0001179110-17-003120 · edgar.xml · derivative · entry 1 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,925 Underlying: Common Stock · 72,925 shares Expires 2027-02-22 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:06 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 45,568 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003119 · edgar.xml · derivative · entry 2 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,568 Underlying: Common Stock · 45,568 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:06 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
GrantOption to Purchase Common Stock · Derivative | 72,925 | $0.00 Strike: $12.07 | $0.00 |
DisclosureSEC source: 0001179110-17-003119 · edgar.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,925 Underlying: Common Stock · 72,925 shares Expires 2027-02-22 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:05 UTC |
Stelzer LaurieSVP, Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 45,568 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003117 · edgar.xml · derivative · entry 2 Stelzer Laurie · CIK 0001644348 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,568 Underlying: Common Stock · 45,568 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:05 UTC |
Stelzer LaurieSVP, Chief Financial Officer
|
GrantOption to Purchase Common Stock · Derivative | 72,925 | $0.00 Strike: $12.07 | $0.00 |
DisclosureSEC source: 0001179110-17-003117 · edgar.xml · derivative · entry 1 Stelzer Laurie · CIK 0001644348 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,925 Underlying: Common Stock · 72,925 shares Expires 2027-02-22 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:05 UTC |
Gergen Mark JSVP, Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 45,568 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003118 · edgar.xml · derivative · entry 2 Gergen Mark J · CIK 0001373110 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,568 Underlying: Common Stock · 45,568 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:05 UTC |
Gergen Mark JSVP, Chief Operating Officer
|
GrantOption to Purchase Common Stock · Derivative | 72,925 | $0.00 Strike: $12.07 | $0.00 |
DisclosureSEC source: 0001179110-17-003118 · edgar.xml · derivative · entry 1 Gergen Mark J · CIK 0001373110 · SVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,925 Underlying: Common Stock · 72,925 shares Expires 2027-02-22 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:04 UTC |
Torley HelenDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 157,416 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-003116 · edgar.xml · derivative · entry 2 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,416 Underlying: Common Stock · 157,416 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:04 UTC |
Torley HelenDirector · President and CEO
|
GrantOption to Purchase Common Stock · Derivative | 251,923 | $0.00 Strike: $12.07 | $0.00 |
DisclosureSEC source: 0001179110-17-003116 · edgar.xml · derivative · entry 1 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,923 Underlying: Common Stock · 251,923 shares Expires 2027-02-22 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 21:39 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 31,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001873 · edgar.xml · derivative · entry 2 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 31,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F1 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 21:39 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001873 · edgar.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 18,496 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001809 · edgar.xml · derivative · entry 3 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,487 Underlying: Common Stock · 18,496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F2 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 6,900 | $12.26 | $84,594.00 |
DisclosureSEC source: 0001179110-17-001809 · edgar.xml · nonDerivative · entry 2 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,077 F1 · shares: The reported disposition of 6,900 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 18,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001809 · edgar.xml · nonDerivative · entry 1 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 15,413 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001810 · edgar.xml · derivative · entry 3 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,239 Underlying: Common Stock · 15,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F2 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Tax withholdingCommon Stock | 6,198 | $12.26 | $75,987.48 |
DisclosureSEC source: 0001179110-17-001810 · edgar.xml · nonDerivative · entry 2 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,507 F1 · shares: The reported disposition of 6,198 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
LEONHARDT HARRY JSVP, GC and CCO
|
Exercise / conversionCommon Stock | 15,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001810 · edgar.xml · nonDerivative · entry 1 LEONHARDT HARRY J · CIK 0001286102 · SVP, GC and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:00 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 55,487 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001807 · edgar.xml · derivative · entry 2 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,461 Underlying: Common Stock · 55,487 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F1 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:00 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 55,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001807 · edgar.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Stelzer LaurieSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 23,120 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001808 · edgar.xml · derivative · entry 4 Stelzer Laurie · CIK 0001644348 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,358 Underlying: Common Stock · 23,120 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F3 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Stelzer LaurieSVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 9,085 | $12.26 | $111,382.10 |
DisclosureSEC source: 0001179110-17-001808 · edgar.xml · nonDerivative · entry 2 Stelzer Laurie · CIK 0001644348 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,910 F1 · shares: The reported disposition of 9,085 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 00:01 UTC |
Stelzer LaurieSVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 23,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-001808 · edgar.xml · nonDerivative · entry 1 Stelzer Laurie · CIK 0001644348 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 21:04 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000757 · edgar.xml · derivative · entry 2 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F1 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 21:04 UTC |
Torley HelenDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000757 · edgar.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:03 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000756 · edgar.xml · derivative · entry 2 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F1 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 21:03 UTC |
Countouriotis AthenaSVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000756 · edgar.xml · nonDerivative · entry 1 Countouriotis Athena · CIK 0001571469 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.